Details for Patent: 7,858,789

Summary for Patent: 7,858,789

Title:	Derivatives of 4-aminopiperidine and their use as a medicament
Abstract:	A subject of the present application is new derivatives of 4-aminopiperidines of formula ##STR00001## in which R.sub.1, R.sub.2 and R.sub.3 represent various radical, and their preparation processes by synthetic methods in parallel in liquid and solid phase. These products having a good affinity with certain sub-types of somatostatin receptors, they are particularly useful for treating the pathological states or diseases in which one (or more) somatostatin receptors are involved.
Inventor(s):	Thurieau; Christophe (Paris, FR), Gonzalez; Jerome (Annemasse, FR), Moinet; Christophe (Montreal, CA)
Assignee:	Ipsen Pharma S.A.S. (Boulogne-Billancourt, FR)
Application Number:	12/151,115
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,858,789
Patent Claim Types: see list of patent claims	Compound;

Drugs Protected by US Patent 7,858,789

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 7,858,789

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
France	99 15724	Dec 14, 1999

International Family Members for US Patent 7,858,789

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	034244
Austria	401308
Australia	2856001
Australia	779341
Canada	2394086